Long term treatment with insulin-stimulating agent, nateglinide, ameliorates insulin resistance in type 2 diabetic patients

被引：0
|
作者：
Inukai, Kouichi
Nakashima, Youhei
Ikegami, Yuichi
Imai, Kenta
Awata, Takuya
Katayama, Shigehiro
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A483 / A483
页数：1
相关论文
共 50 条
  • [1] Pitavastatin Ameliorates Insulin Resistance in Type 2 Diabetic Patients: Report of Two Cases
    Satoh, Hiroaki
    Kudoh, Akihiro
    Hirai, Hiroyuki
    Watanabe, Tsuyoshi
    JOURNAL OF DIABETES & METABOLISM, 2013, 4 (01)
  • [2] Barriers of the initiation of insulin treatment in type 2 diabetic patients conquering the "psychological insulin resistance"
    Racz Oliver
    Linkova Marcela
    Jakubowski Krzysztof
    Link, Robert
    Kuzmova Daniela
    ORVOSI HETILAP, 2019, 160 (03) : 93 - 97
  • [3] Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
    Hazama, Y
    Matsuhisa, M
    Ohtoshi, K
    Gorogawa, S
    Kato, K
    Kawamori, D
    Yoshiuchi, K
    Nakamura, Y
    Shiraiwa, T
    Kaneto, H
    Yamasaki, Y
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (03) : 251 - 255
  • [4] The leptin-stimulating effect of insulin predicts weight gain during long term insulin treatment in type 2 diabetes
    Birkeland, KI
    Aas, AM
    Johannesen, O
    Thorsby, P
    Berg, JP
    DIABETES, 2002, 51 : A408 - A408
  • [5] THE LONG TERM EFFICACY OF INSULIN TREATMENT IN TYPE 2 DIABETIC PATIENTS, 36-MONTHS OBSERVATION PERIOD
    Farcasiu, E.
    ATHEROSCLEROSIS, 2014, 235 (02) : E190 - E190
  • [6] Discriminant Model for Insulin Resistance in Type 2 Diabetic Patients
    Lopez-Galan, Erislandis
    Barrio-Deler, Rafael
    Fernandez-Fernandez, Manuel Alejandro
    Del Toro-Delgado, Yaquelin
    Penuela-Puente, Isaac Enrique
    Sanchez-Hechavarria, Miguel Enrique
    Munoz-Bustos, Mario Eugenio
    Munoz-Bustos, Gustavo Alejandro
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [7] Exenatide or Glimepiride on Insulin Resistance in Type 2 Diabetic Patients
    Derosa, Giuseppe
    Putignano, Pietro
    Bossi, Antonio C.
    Bianchi, Lucio
    Querci, Fabrizio
    Franzetti, Ivano G.
    Guazzini, Barbara
    Testori, Giampaolo
    Fogari, Elena
    Maffioli, Pamela
    DIABETES, 2011, 60 : A294 - A294
  • [8] LONG-TERM INSULIN-TREATMENT IN 2 NON-DIABETIC PATIENTS
    ASPLUND, J
    AHLMARK, G
    GUNNARSSON, R
    OSTMAN, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (08): : 870 - 870
  • [9] Long-term effect of insulin resistance on the development of coronary artery disease in Japanese type 2 diabetic patients
    Wasada, T
    Kuroki, H
    Katsumori, K
    Iwamoto, Y
    DIABETES, 2002, 51 : A174 - A174
  • [10] Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis
    Abe, Masanori
    Okada, Kazuyoshi
    Maruyama, Takashi
    Maruyama, Noriaki
    Soma, Masayoshi
    Matsumoto, Koichi
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1611 - 1620
12345